1. Home
  2. LTRN vs BLIV Comparison

LTRN vs BLIV Comparison

Compare LTRN & BLIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • BLIV
  • Stock Information
  • Founded
  • LTRN 2013
  • BLIV 2014
  • Country
  • LTRN United States
  • BLIV Singapore
  • Employees
  • LTRN N/A
  • BLIV N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • BLIV
  • Sector
  • LTRN Health Care
  • BLIV
  • Exchange
  • LTRN Nasdaq
  • BLIV NYSE
  • Market Cap
  • LTRN 38.0M
  • BLIV 39.8M
  • IPO Year
  • LTRN 2020
  • BLIV 2025
  • Fundamental
  • Price
  • LTRN $3.73
  • BLIV $4.34
  • Analyst Decision
  • LTRN Buy
  • BLIV
  • Analyst Count
  • LTRN 2
  • BLIV 0
  • Target Price
  • LTRN $25.00
  • BLIV N/A
  • AVG Volume (30 Days)
  • LTRN 43.8K
  • BLIV 603.2K
  • Earning Date
  • LTRN 05-08-2025
  • BLIV 01-01-0001
  • Dividend Yield
  • LTRN N/A
  • BLIV N/A
  • EPS Growth
  • LTRN N/A
  • BLIV N/A
  • EPS
  • LTRN N/A
  • BLIV N/A
  • Revenue
  • LTRN N/A
  • BLIV $1,915,838.00
  • Revenue This Year
  • LTRN N/A
  • BLIV N/A
  • Revenue Next Year
  • LTRN N/A
  • BLIV N/A
  • P/E Ratio
  • LTRN N/A
  • BLIV N/A
  • Revenue Growth
  • LTRN N/A
  • BLIV N/A
  • 52 Week Low
  • LTRN $2.55
  • BLIV $2.69
  • 52 Week High
  • LTRN $7.21
  • BLIV $6.40
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 55.76
  • BLIV N/A
  • Support Level
  • LTRN $3.00
  • BLIV N/A
  • Resistance Level
  • LTRN $3.71
  • BLIV N/A
  • Average True Range (ATR)
  • LTRN 0.36
  • BLIV 0.00
  • MACD
  • LTRN 0.08
  • BLIV 0.00
  • Stochastic Oscillator
  • LTRN 85.51
  • BLIV 0.00

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: